Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats (original) (raw)
Effect of telmisartan in limiting the cardiotoxic effect of daunorubicin in rats
Rajarajan Amirthalingam Thandavarayan
Journal of Pharmacy and Pharmacology, 2010
View PDFchevron_right
Angiotensin-converting enzyme inhibition and angiotensin AT 1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity
Ibrahim Gomaa
Pharmacological Research, 2009
View PDFchevron_right
Ameliorating the anticancer drug ”Adriamycin” acute Cardiotoxicity by Rosuvastatin and Telmisartan in rats
Ali Al-Gareeb
View PDFchevron_right
The Potential Role of Thioctic Acid in the Attenuation of Doxorubicin Induced-Cardiotoxicity
hayder M Al-kuraishy
Open Access Journal of Oncology and Medicine
View PDFchevron_right
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment
Christian Cadeddu
American Heart Journal, 2010
View PDFchevron_right
Drugs Against Doxorubicin Induced Cardiotoxicity 33: 203-207 Short Communication Doxorubicin Induced Cardiotoxicity and Its Modulation by Drugs
Shahid Karim
Indian Journal of Pharmacology
View PDFchevron_right
Cardiotoxicity of doxorubicin: Causes, diagnosis, consequences and possibilities of prevention
Milana Bosanac
Hospital Pharmacology - International Multidisciplinary Journal
View PDFchevron_right
Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction
Christian Cadeddu
Experimental and therapeutic medicine, 2011
View PDFchevron_right
Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response
Najah Hadi
BMC Cardiovascular Disorders, 2012
View PDFchevron_right
Acute and Delayed Doxorubicin-Induced Myocardiotoxicity Associated with Elevation of Cardiac Biomarkers, Depletion of Cellular Antioxidant Enzymes, and Several Histopathological and Ultrastructural Changes
اشرف البركاتي
Life
View PDFchevron_right
ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat
Mario Bigioni
Vascular Pharmacology, 2009
View PDFchevron_right
Duxorubicin-induced cardiotoxicity
Mukund Joshi
International Journal of Basic & Clinical Pharmacology, 2015
View PDFchevron_right
Evaluation of Ameliorative Effect of Quercetin and Candesartan in Doxorubicin-Induced Cardiotoxicity
Mohd Yasir
Vascular Health and Risk Management, 2022
View PDFchevron_right
Ameliorative Potential of Rosuvastatin on Doxorubicin-induced Cardiotoxicity
Jayaraman Rajangam
Ameliorative Potential of Rosuvastatin on Doxorubicin-induced Cardiotoxicity , 2022
View PDFchevron_right
Ameliorative Potential of Rosuvastatin on Doxorubicin-induced Cardiotoxicity by Modulating Oxidative Damage in Rats
NAVANEETHA KRISHNAN
Turkish Journal of Pharmaceutical Sciences, 2021
View PDFchevron_right
Molecular Mechanisms of Cardiotoxicity: A Review on Major Side-effect of Doxorubicin
Abolfazl Faraji
Indian Journal of Pharmaceutical Sciences
View PDFchevron_right
Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats
Mohamed El-Moselhy
Environmental Toxicology and Pharmacology, 2013
View PDFchevron_right
Treatment Of Albino Rats With Oltipraz (4-MethyL-5-PyrazinyL-3H-1,2-Dithiole-3-Thione Protects Against Doxorubicin-Induced Cardiotoxicity
Ganesh Jagetia
2022
View PDFchevron_right
Fighting doxorubicin-induced cardiotoxicity with adiponectin
C. McTiernan
Cardiovascular Research, 2011
View PDFchevron_right
1261 POSTER Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction
Clelia Madeddu
European Journal of Cancer, 2011
View PDFchevron_right
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Entsar Saad
The Egyptian Heart Journal
View PDFchevron_right
A Review on Anthracycline Induced Cardiotoxicity- A Mechanism-based Approach
Sachin Hiradeve
Journal of Pharmaceutical Research International
View PDFchevron_right
The decrease of NAD(P)H:quinone oxidoreductase 1 activity and increase of ROS production by NADPH oxidases are early biomarkers in doxorubicin cardiotoxicity
Carlos H Gañán
Biomarkers, 2014
View PDFchevron_right
Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice
Emanuelle de Souza Santos
Cancer Chemotherapy and Pharmacology, 2015
View PDFchevron_right
Doxorubicin-Induced Cardiotoxicity: Molecular Mechanism and Protection by Conventional Drugs and Natural Products
Ali Al-Gareeb
2017
View PDFchevron_right
Anthracycline-Induced Cardiotoxicity
André Ferreira
Cardiovascular & Hematological Agents in Medicinal Chemistry (formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), 2008
View PDFchevron_right
Protective Effects Of Melatonin On Doxorubicin Induced Cardiotoxicity In Isolated Rat Heart
zeynep erdogmus
Eastern Journal Of Medicine, 2016
View PDFchevron_right
Protective role of atorvastatin against doxorubicin-induced cardiotoxicity and testicular toxicity in mice
Ajit Vikram
Journal of Physiology and Biochemistry, 2013
View PDFchevron_right
Combined effects of p-coumaric acid and naringenin against doxorubicin-induced cardiotoxicity in rats
Shruti Shiromwar
Pharmacognosy Research, 2011
View PDFchevron_right